NCT02327169 2020-02-25A Study MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Participants With Advanced Nonhematologic MalignanciesTakedaPhase 1 Completed81 enrolled 33 charts